Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly
throughout the world, causing severe morbidity and mortality. Since the first reports of …

Coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) poses serious global public health problems. Characterization of the …

Recent progress on chimeric antigen receptor (CAR)-NK cells has shown promising results
in treating CD19-positive lymphoid tumors with minimal toxicities [including graft versus host …

Introduction. Morbidity and mortality of COVID-19 actualizes the identification of groups with
the greatest risk of primary and re-infection, persons in need of priority vaccination or …

Dried blood spots (DBS) provide easy handling and are thus a beneficial tool for data
collection, eg for epidemiological studies. The suitability of DBS for the assessment of …

Between 2 and 8.5% of patients who recover from COVID-19 do not develop antibodies, and
the durability of IgG antibodies is under scrutiny. Therefore, the presence and persistence of …

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) was first reported in December 2019 and spread rapidly and …

Introduction: Severe respiratory failure is one of the most serious complications of
coronavirus disease 2019 (COVID-19). In a small proportion of patients, mechanical …

Evaluación de factores que influyen en la severidad de la infección por SARS-CoV-2 Page 1
Centro de Investigaciones Biomédicas Región Xalapa Doctorado en Ciencias Biomédicas …

El virus Zika (ZIKV, por sus siglas en inglés) es de gran relevancia para la salud pública,
desde su introducción en 2015 en el continente americano (Zanluca et al., 2015) y en …